A Multicenter Study to Evaluate the Efficacy of DR-105 for Menstrually-Related Migraine Headaches
| Status: | Archived |
|---|---|
| Conditions: | Migraine Headaches |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | November 2008 |
| End Date: | June 2011 |
A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy of DR-105 Compared to Placebo For the Management of Menstrually-Related Migraine Headaches.
This study is being conducted to evaluate the efficacy of DR-105 compared to placebo for
decreasing the frequency and severity of menstrually-related migraine headaches.
This is a multicenter, randomized, study to evaluate and compare the frequency and severity
of menstrually-related migraine headaches before and during the 7-day ethinyl estradiol
monotherapy interval in women treated with DR-105 compared to placebo during the 91-day
treatment period.
We found this trial at
19
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials